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Abstract
Background: The European Health Literacy Survey Questionnaire (HLS-EU-Q47) is widely used in assessing health
literacy (HL). There has been some controversy whether the comprehensive HLS-EU-Q47 data, reflecting a
conceptual model of four cognitive domains across three health domains (i.e. 12 subscales), fit unidimensional
Rasch models. Still, the HLS-EU-Q47 raw score is commonly interpreted as a sufficient statistic. Combining Rasch
modelling and confirmatory factor analysis, we reduced the 47 item scale to a parsimonious 12 item scale that
meets the assumptions and requirements of objective measurement while offering a clinically feasible HL screening
tool. This paper aims at (1) evaluating the psychometric properties of the HLS-EU-Q47 and associated short versions
in a large Norwegian sample, and (2) establishing a short version (HLS-Q12) with sufficient psychometric properties.
Methods: Using computer-assisted telephone interviews during November 2014, data were collected from 900
randomly sampled individuals aged 16 and over. The data were analysed using the partial credit parameterization
of the unidimensional polytomous Rasch model (PRM) and the ‘between-item’ multidimensional PRM, and by using
one-factorial and multi-factorial confirmatory factor analysis (CFA) with categorical variables.
Results: Using likelihood-ratio tests to compare data-model fit for nested models, we found that the observed HLS-
EU-Q47 data were more likely under a 12-dimensional Rasch model than under a three- or a one-dimensional
Rasch model. Several of the 12 theoretically defined subscales suffered from low reliability owing to few items.
Excluding poorly discriminating items, items displaying differential item functioning and redundant items violating
the assumption of local independency, a parsimonious 12-item HLS-Q12 scale is suggested. The HLS-Q12 displayed
acceptable fit to the unidimensional Rasch model and achieved acceptable goodness-of-fit indexes using CFA.
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Conclusions: Unlike the HLS-EU-Q47 data, the parsimonious 12-item version (HLS-Q12) meets the assumptions and
the requirements of objective measurement while offering clinically feasible screening without applying advanced
psychometric methods on site. To avoid invalid measures of HL using the HLS-EU-Q47, we suggest using the HLS-
Q12. Valid measures are particularly important in studies aiming to explain the variance in the latent trait HL, and
explore the relation between HL and health outcomes with the purpose of informing policy makers.
Keywords: Confirmatory factor analysis of categorical data, Health literacy, HLS-EU-Q47, HLS-Q12, Rasch modelling,
Short version, Validation
Background
Health literacy (HL) is believed to have a vital impact
on public health, including access to and the use of
health services [1–3]. Low HL is associated with poorer
health conditions [3, 4], more frequent use of health
services, longer hospitalisations [2, 3] and higher mortality
[4, 5]. Further, some studies relate low HL to unhealthy
behaviours, such as smoking [1, 6–9], low physical activity
[7–12] and less use of preventive services [1, 4, 7]. Several
instruments have been developed to measure individuals’
HL and explore how health outcomes relate to HL. Some
instruments assess basic reading and writing skills (such
as the Test of Functional HL in Adults [TOFHLA] [13]
and the Rapid Estimate of Adult Literacy in Medicine
[REALM] [14]), while others assess specific health and
cognitive domains (such as the European Health Literacy
Survey Questionnaire [HLS-EU-Q47] [11, 15]). The
HLS-EU-Q47 was developed from a conceptual model
covering four cognitive domains within three health
domains, which constitutes a 12-cell matrix for item
development [16]. The cognitive domains comprise the
proficiency to access (A), understand (B), appraise (C) and
apply (D) health information. These competencies are
considered necessary to handle health information within
health care (HC), disease prevention (DP) and health pro-
motion (HP) settings.
The psychometric properties of the HLS-EU-Q47 have
been investigated using principal component analysis
(PCA) [15] and confirmatory factor analysis (CFA) [17–19].
When applying CFA in these studies, the health domains
were treated as three uncorrelated or orthogonal subscales
confirming a four-component structure reflecting the four
cognitive domains. A Norwegian study among individuals
with type 2 diabetes [20], in which the HLS-EU-Q47 was
validated using Rasch-modelling in combination with CFA,
revealed that the three health domains were highly corre-
lated and that a 12-dimensional model (reflecting the four
cognitive domains across the three health domains in the
conceptual framework) obtained the best data-model fit.
These results were later confirmed in a Taiwanese study
among stroke patients [21]. A 12-dimensional scale requires
a multidimensional approach and provides 12 different
scores for each individual, which is impractical in clinical
settings. Despite the theoretically identified and empirically
confirmed multidimensionality of the HLS-EU-Q47, several
studies assume a unidimensional latent variable and report
one overall HL sum score [3, 9, 11, 17–19, 22–24]. Beside
multidimensionality, researchers have observed items with
poor fit, redundant items, items displaying unordered re-
sponse categories and subscales with low precision or reli-
ability [20, 21]. Therefore, we aim to clarify these issues
based on a large sample of randomly selected individuals.
A unidimensional short version of the HLS-EU-Q47
will provide clinically useful data in a fast, reliable and
accurate manner without applying advanced psychom-
etry. Moreover, measurement scales should be anchored
in theory and conceptual frameworks [25]. Hence, it is
desirable that the short version reflects the conceptual
HL model of Sørensen et al. [16], and that the 12 do-
mains are equally represented. In addition, nurses and
other health professionals should be able to use the
short version to map patients’ HL without applying ad-
vanced psychometric approaches. Several short versions
of the HLS-EU-Q47 have been suggested, such as the
HLS-EU-Q16 [11] and HL-SF12 [26]. However, we did
not find any peer-reviewed publications describing the
basis on which the items were selected, whether these
short versions were validated using Rasch modelling, or
whether they are sufficiently unidimensional. Therefore,
based on the findings of Finbråten et al. [20] and the val-
idation procedure in the present study, Rasch modelling
and CFA are used to establish a unidimensional 12 item
version of the HLS-EU-Q47.
Rasch models meet the assumptions and requirements
of fundamental measurement, such as additivity [27],
specific objectivity [28], sufficiency [29] and invariance
[30]. Both Rasch modelling and CFA can be considered
appropriate methods for assessing dimensionality [31, 32].
CFA is used at an overall level to assess discriminant
validity (dimensionality) and factorial validity (loadings or
common variance), whereas Rasch modelling in addition
provide detailed information at the item level, in addition
to assessing local independency.
Against this background, the aims of our paper are to: (1)
evaluate the psychometric properties of the HLS-EU-Q47
and associated short versions in the Norwegian population
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and (2) establish a parsimonious unidimensional short
version (HLS-Q12) with sufficient psychometric prop-
erties. More specifically, we will test the following falsifi-
able hypothesis: When applied to Norwegian adults, the
HLS-EU-Q47 represents a unidimensional, well-targeted
scale with acceptable person separation (reliability), con-
sisting of independent and invariant items at the ordinal
level (i.e., ordered response categories) each displaying
sufficient fit to the partial-credit parameterisation of the
unidimensional polytomous Rasch-model.
The same hypothesis is tested for the HLS-Q12, and is
used as a basis for comparing the psychometric proper-
ties of HLS-Q12 to the HL-SF12 and the HLS-EU-Q16.
Methods
Data collection
A random sample of 900 Norwegians aged 16 and over
responded to the HLS-EU-Q47 during November 2014.
For comparative purposes, we initially aimed at applying
identical data collection procedures as the European HL
survey [11], but owing to personal resources, it was not
possible to perform face-to-face interviews. Hence, data
were collected using computer-assisted telephone inter-
views. The international survey agency, Ipsos, with access
to country representative samples, collected the data fol-
lowing detailed instructions offered by the researchers.
The European HL survey sampled approximately 1000 re-
spondents in each participating country [11] independent
of population size. As there are significantly fewer inhabi-
tants in Norway compared to most of the countries that
participated in the European HL survey [33], 900 were
sampled. The age limit was set to 16 years as this is the
age of licence in relation to health in Norway.
Measures
The measures included the 47 items HLS-EU-Q47 HL
survey questionnaire and additional person factors, such
as gender, age and highest level of education completed.
The HLS-EU-Q47
Sørensen et al. [11, 15] developed the HLS-EU-Q47 items
to reflect their conceptual model, and suggested a 4-point
rating scale with response categories ranging from very
easy (1) to very difficult (4). In the present study, the rat-
ing scale was reversed to make a higher score indicate a
higher proficiency at the latent trait. A ‘don’t know’ cat-
egory, which was later recoded to missing data, was added
to record such spontaneous utterings from respondents
during the telephone interviews.
Translation of the HLS-EU-Q47
The translation procedure, that involved forward and
back translation, is thoroughly described in Finbråten et
al. [20]. Cognitive interviews were used to explore item
interpretation and clarify any ambiguities.
Data analysis
Rasch modelling was used to assess the psychometric
properties of the HLS-EU-Q47 and as a basis for develop-
ing the HLS-Q12. Rasch modelling and CFA were used to
study the psychometric properties of the short versions
HLS-Q12 (our suggested short version), HL-SF12 [26]
and the HLS-EU-Q16 [11].
The data were analysed up against the partial-credit
parameterisation [34] of the unidimensional polytomous
Rasch model (PRM) and the ‘between-item’ multidimen-
sional PRM [35, 36]. Below, the one-dimensional ap-
proach refers to unidimensional Rasch analysis. The
two- and three-dimensional approaches refer to an ob-
lique or unrestricted multidimensional Rasch analysis
where the health domains are allowed to covary. The
two-dimensional approach corresponds to the HC sub-
scale and the combined DP and HP subscales, whereas
the three-dimensional approach reflects the three health
domains. The 12-dimensional approach refers to a simi-
lar analysis, where the four cognitive domains and the
three health domains define 12 correlated subscales.
The RUMM2030 statistical software package [37] was
used for the one-dimensional and consecutive Rasch
analyses (treating the subscales as orthogonal or
uncorrelated), and the ConQuest 4 statistical software
package [38] was used for the one-dimensional and
multidimensional Rasch analyses. CFA was performed
using LISREL9.3 software [39].
Rasch modelling
The null hypothesis of a locally independent scale is
weakened and might be rejected in favour of the alter-
native hypothesis, suggesting a multidimensional scale,
in the following situations: When the proportion of
individuals with significantly different person-location
estimates on a pair of related subscales exceeds 5% (or
the lower bound of the binominal 95% confidence
interval (CI) exceeds 5%) [40–43]; when the subtest
analysis in RUMM points to low common subscale vari-
ance and high unique subscale variance (i.e. low fractal
index A < 0.8 and high fractal index c close to 0.5, respect-
ively) [44]; when a multidimensional Rasch model obtains
a better data-model fit than a one-dimensional Rasch
model (i.e. significantly lower deviance or -2log-likeli-
hoods using a likelihood-ratio test for nested models and
AIC for non-nested models) [45]; and/or when absolute
values of Rasch-model residual correlations among items
exceed 0.3 [46].
Likelihood-ratio tests (LRT) were used to compare
data-model fit for nested models, such as the one-, two-,
three- and 12-dimensional Rasch models, where the first
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implies parallel subscales (correlations between all theor-
etically defined subscales were fixed at 1) and the latter
implies freely correlated subscales. The LRT statistic
“difference in deviance” is asymptotically χ2 distributed
with degrees of freedom (df ) equal to the difference in
the number of estimated model parameters comparing
two nested models [47]. Akaike’s information criterion
(AIC) [48] was used to compare the data-model fit for
non-nested models, such as the various short versions.
Similar to Allen and Wilson [49], both deviance and
AIC are reported when applying the consecutive ap-
proach to the HLS-EU-Q47 (calculated by adding the
values for each of the three subscales). Lower values of
deviance and AIC indicate better data-model fit. In
addition to deviance and AIC, total item chi-square with
p-values was used to assess the data-model fit of the
short versions.
Items were interpreted as under−/over-discriminating
relative to the Rasch model when the infit MNSQ were sig-
nificantly different from the expected value of 1 (indicating
perfect fit to model) or, more precisely, when the infit value
was above/below the 95% CI and the corresponding t value
was > 1.96 [45, 50].
In addition to infit, chi-square probability was used to
assess item fit for the various short versions. Items were
considered as misfitting at high chi-square values and
probability values lower than a Bonferroni-adjusted 5%
[51]. Item difficulty was described using item-location
estimates.
Applying the consecutive approach to the HLS-EU-Q47
and the one-dimensional approach to the short versions,
differential item functioning (DIF) was explored using
analysis of variance (ANOVA) [40] for the dichotomized
person factors of gender, age and level of highest com-
pleted education: age was dichotomised as above or below
the sample mean (47 years), and highest level of com-
pleted education was split into “compulsory and upper
secondary school” versus “university level”.
The ordering of the response categories was examined
applying the one-dimensional and the consecutive ap-
proaches. Significantly different thresholds in “correct”
order [52, 53] were used as evidence for ordered re-
sponse categories. The targeting of the (sub)scales was
evaluated by comparing the distribution of the item
threshold estimates to the distribution of the person es-
timates [51]. For more detailed descriptions of the ana-
lyses performed, see for example, Andrich [30], Hagquist
[53], Hagquist, Bruce and Gustavsson [54] or Finbråten
et al. [20].
Confirmatory factor analysis
The null hypothesis of a one-dimensional scale is weak-
ened when overall fit indexes for multifactorial CFA are
superior to a one-factorial CFA [55]. Owing to categorical
raw data, we defined the variables as ordinal in the “lsf”
file and estimated the polychoric item correlations and
their asymptotic covariance matrix using the PRELIS
application to LISREL [56]. As target values for
goodness-of-fit (GOF) indexes is based on maximum
likelihood estimation (ML), we used robust ML to ob-
tain the Satorra-Bentler scaled chi-square GOF index
(SB scaled χ2) [57, 58]. The following overall GOF in-
dexes for model comparison based on the null model
were used: SB scaled χ2, standardized root mean square
residual (SRMR), root mean square error of approxima-
tion (RMSEA), comparative fit index (CFI) and
non-normed fit index (NNFI, or Tucker-Lewis index
[TLI]). Schumacker and Lomax [59] recommend SRMR
< .05, RMSEA ≤ .05, and CFI and NNFI ≥ .95 as GOF
index target values, whereas Hu and Bentler [60] claim
that SRMR and RMSEA values close to or below 0.8
and 0.6, respectively, indicate sufficient overall fit. The
AIC and the Bayesian information criterion (BIC) were
also taken into account. AIC and GOF indexes were
used to compare the various short versions and to
compare the one-factor to the three-factor approaches
for the various short versions. Item communalities
(squared factor loadings for completely standardized
solution) describe the shared variance among the items
that is accounted for by the latent variable, HL [61].
Reliability
Person separation index (PSI), person separation reliability
(PSR) and the H coefficient [62] (obtained from RUMM,
ConQuest and calculated manually based on communal-
ities from CFA) were used as measures of reliability.
Values exceeding 0.85 (0.65) are sufficient if conclusions
are to be drawn at the individual (group) level [63].
Developing a one-dimensional short version
The suggested short version in the present study, the
HLS-Q12, was developed from analyses of the
HLS-EU-Q47 in two Norwegian samples; people with
type 2 diabetes [20] and the general population. The sug-
gested version, HLS-Q12, was developed by stepwise ex-
clusion of poorly fitting items, items displaying DIF and
items collecting redundant information, together with a
qualitative evaluation of the item content in light of the
conceptual framework. For dependent items, the item
with the most essential information was retained, while
the other item was discarded. We ensured that the items
in our final scale (specified in Table 5) were distributed
across the HLS-EU 12-cell matrix [11, 16].
Missing data
The dataset we analysed was complete, but there was, on
average, 29 (3%) ‘don’t know’ responses per item, which
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we recoded as missing values. Item 2 had the highest
number of ‘don’t know’ responses (69 or 8%). Rasch mod-
elling was performed on incomplete data (except in the
subtest analyses), whereas LISREL used list-wise deletion
as the default method, reducing the sample size from 900
to effective sample sizes of 699, 680 and 670 for the
HLS-Q12, HL-SF12 and the HLS-EU-Q16, respectively.
Results
The sample (n = 900) distributions for gender and age
reflected the population distributions, while individuals
with higher education were somewhat over-sampled
(Table 1).
Psychometric properties of the HLS-EU-Q47
Overall analyses of HLS-EU-Q47
Overall analyses included those for dimensionality,
data-model fit, response dependence and reliability. The
initial analyses of dimensionality indicated that neither
the entire HLS-EU-Q47 nor the three health domains,
HC, DP and HP, were sufficiently unidimensional (the
respective proportions of significant t-tests were 21, 9,
13 and 10% [not reported in Table 2]).
Using LRT, the observed data were more likely under a
12-dimensional Rasch model than a one-, two- or
three-dimensional Rasch model (Fig. 1). As expected, the
data-model fit improved significantly in each step from
the one-dimensional through the 12-dimensional model.
For example, the drop in deviance from the three- to the
12-dimensional model was ΔD = 3878 ≈ χ2 [Δdf =Δesti-
mated parameters (ep) = 72], p < 0.01, critical value = 103.
The three-dimensional model had a lower AIC and a bet-
ter fit than the consecutive approach of the three health
domains, HC, DP and HP (ΔAIC = 1129). The correlations
between HC and DP, HC and HP, and DP and HP were
r = 0.81, 0.71 and 0.83, respectively.
Applying the one-dimensional approach, we observed
nine pairs of dependent items (1 and 2, 22 and 23, 41
and 42, 44 and 46, 45 and 47, 3 and 7, 12 and 28, 17 and
21, 30 and 37), of which the latter four pairs surprisingly
appeared across the theoretically defined subscales.
Applying the consecutive approach to the three health
domains, only one pair of dependent items was observed
within each health domain (1 and 2, 17 and 21, and 41
and 42, respectively).
Applying the 12-dimensional approach to the
HLS-EU-Q47, we observed relatively low subscale reli-
ability indexes, most likely owing to few items per
scale—on average 3.9 items per subscale (see PSR
values in Fig. 1). Consequently, we observed acceptable
reliability indexes for the one-dimensional approach
and for the subscales of the two- and the three-dimensional
approaches.
Analyses of HLS-EU-Q47 at item level
Analyses at the item level included analyses of item fit,
item discrimination, DIF and ordering of response cat-
egories. Table 2 shows the item fit when applying the
one-, three- and 12-dimensional approaches.
Under-discriminating items were observed using the
one- (items 12, 29, 38, 45 and 47), three- (items 11, 12, 29,
30 and 38) and 12-dimensional (items 12, 18, 19, 38 and
43) approaches; items 12 and 38 under-discriminated in
all analysis approaches. Over-discriminating items were
also observed when the one- (items 16, 19, 20 and 40),
three- (items 8 and 40) and 12- dimensional (item 16) ap-
proaches were applied. Using the consecutive approach,
several items displayed DIF (Table 2).
Unordered response categories were observed for
items 8, 15 and 21 when applying the one-dimensional
approach, as well as when analysing the HC, DP and HC
health domains consecutively (Table 2).
Table 1 Characteristics of study sample and the Norwegian
population
Sample
(n = 900)
Populationa
(N = 4,115,195)
Age
mean ± sd 47.0 ± 17.7 46.5 ± 19.0
- median 48 45
- min−max 16−91 16−105
- missing 0 0
% %
16–24 years 13 15
25–39 years 25 25
40–54 years 25 26
55–66 years 21 17
67–79 years 14 12
80+ years 2 5
Gender n (%) n (%)
- males 441 (49) 2,567,434 (50)
- females 459 (51) 2,541,622 (50)
- missing 0
Highest completed education n (%) %
- compulsory comprehensive school 87 (10) 26
- upper-secondary school 298 (33) 38
- university level, lower degreeb 321 (36) 23
- university level, higher degreec 191 (21) 9
- missing 3 (< 1)
aNorwegian population 16 years and over in 2014 (Statistics Norway, 2017)
bEducation at university or university college for 4 years or less
(Bachelor’s degree)
cEducation at university or university college for 5 years or more (Master’s
degree and/or PhD)
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Psychometric properties of the HLS-EU-Q47 short versions
HLS-Q12, HL-SF12 and HLS-EU-Q16
Overall analyses of the HLS-Q12, HL-SF12 and HLS-EU-Q16
According to the t-tests, none of the short versions
could be deemed sufficiently unidimensional (the
proportions of significant t-tests were above 5% and the
lower binominal 95% CI proportion was 0.07 for both
the HLS-Q12 and the HL-SF12, whereas the lower
binominal 95% CI-proportion was 0.09 for the
HLS-EU-Q16 (Table 3).
Nevertheless, the fractal indexes indicated that the
HLS-Q12 and HL-SF12 had relatively high amounts of
common variance (A = 0.90 and 0.91, respectively), high
subscale correlation (r = 0.80 and 0.87, respectively), and
relatively high unique subscale variance (c = 0.50 and
0.39, respectively).
Using LRT, the data fit better to the three-dimensional
models compared to the one-dimensional models of the
various short versions (three-dimensional models had
significantly lower deviance, except for the HL-SF12,
where the difference was insignificant). The GOF indexes
obtained via CFA were also better for the three-factor
models as compared to the one-factor models of the vari-
ous short versions (Table 4).
Comparing the short versions, the HLS-Q12 obtained
best fit to the Rasch model (had the lowest total item
chi-square value and the lowest AIC; Table 3) whereas
the HL-SF12 obtained best fit when performing CFA
(had the lowest likelihood estimates and the best GOF
indexes). The HLS-Q12 also had acceptable GOF in-
dexes (Table 4). The HLS-EU-Q16 displayed the weakest
overall fit indexes (highest total item χ2 value and high-
est log likelihood estimates).
All the one-dimensional short versions had acceptable
reliability values (PSI and PSR values above 0.75 and the
H coefficient was above 0.82). The HLS-EU-Q16 had the
highest reliability indexes (PSI = 0.830, PSR = 0.826 and
H = 0.882). The reliability indexes were slightly higher
for the HLS-Q12 than for the HL-SF12 (Tables 3 and 4).
Applying the three-dimensional approach, the PSR and
H values of the correlated subscales were below the
recommended values (Tables 3 and 4). The HLS-Q12
was the best-targeted, with a mean person location of
0.759. The mean person locations for the HL-SF12 and
Fig. 1 Model fit of the HLS-EU-Q47 after applying various analysis approaches. Figure 1 shows the overall fit statistics for the one-dimensional
approach (all subscale correlations fixed to 1), the consecutive approach (treating the three health domains as orthogonal or uncorrelated) and
the two-, three- and 12-dimensional approaches (treating the theoretical subscales as correlated). A: access, B: understand, C: appraise, D: apply
(cognitive domains). HC: health care, DP: disease prevention, HP: health promotion (health domains). Δ: change in parameter, AIC: Akaike’s
information criterion, cv: critical value, D: deviance, df: degrees of freedom, ep: number of estimated parameters, LRT: likelihood ratio test. PSR:
person separation reliability based on marginal maximum likelihood estimate/Warm’s mean weighted likelihood estimate
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HLS-EU-Q16 were 0.816 and 1.020, respectively (not
shown in the table).
Analyses of HLS-Q12, HL-SF12 and HLS-EU-Q16 at the item
level
Compared with the HL-SF12 and the HLS-EU-Q16, the
HLS-Q12 showed best fit at the item level as there were
no occurrences of misfitting items, items displaying DIF
with regard to available person factors or items with un-
ordered response categories. For the HL-SF12, items were
within-item biased (items 15, 26 and 30 displayed DIF),
and one item with unordered response categories was ob-
served (item 15). Problems with regard to DIF (items 5,
11, 13, 21 and 37) and unordered response categories
(items 8 and 21) were also observed for the HLS-EU-Q16.
In addition, item 11 under-discriminated and showed
significant misfit (chi-square probability = 0.001; Table 5).
A high level of unique variance was observed for the items
of the various short versions (relatively low communality
values).
Investigating the item-location estimates of the HLS-Q12,
items 28 (judge if the information on health risks in the
media is reliable) and 10 (judge the advantages and disad-
vantages of different treatment options) had the highest
location estimates (1.068 and 0.892, respectively) and were
thus the hardest to endorse. Items 23 (understand why you
need health screenings) and 32 (find information on healthy
activities such as exercise, healthy food and nutrition) were
the easiest to endorse (item-location estimates of − 1.158
and − 1.135, respectively).
Discussion
Based on our national random sample (n = 900), we
found that empirical evidence did not support our null
hypothesis associated with the psychometric properties
of the HLS-EU-Q47. By excluding poorly fitting items,
items displaying DIF and items violating local independ-
ence, we succeeded in establishing a psychometrically
sound parsimonious 12-item version (HLS-Q12). From a
measurement point of view, we found that the HLS-Q12
outperformed other available short versions of the
HLS-EU-Q47, such as the HL-SF12 and the HLS-EU-Q16.
Psychometric properties of the HLS-EU-Q47
Overall analyses of HLS-EU-Q47
A 12-dimensional model described the HLS-EU-Q47
data best. This result is perfectly in line with prior
research [20, 21]. Hence, applying the HLS-EU-Q47
Table 3 Unidimensionality, data-model fit and reliability applying Rasch modelling of the various short versions
HLS-Q12a HL-SF12 [26] HLS-EU-Q16 [11]
One-dimensional Three-
dimensional
One-dimensional Three-
dimensional
One-dimensional Three-
dimensional
Unidimensionality
Proportion (%) of significant
t-tests (lower CI-prop)
8.78% (0.07) 8.01% (0.07) 10.44% (0.09)
PSI 0.767 0.759 0.830
PSIb 0.687 0.668 0.703
Fractal indexes na na na
c 0.50 0.39 0.46
A 0.90 0.91 0.85
r 0.80 0.87 0.82
Total item chi square (df),
probability
112.61 (108),
0.361
130.21 (108),
0.072
208.90 (144),
0.00034
Log-likelihoods
Deviance (ep) 18,590 (37) 18,556 (42) 18,707 (37) 18,696 (42) 22,964 (49) 22,815 (54)
AIC (ep) 18,664 (37) 18,640 (42) 18,781 (37) 18,780 (42) 23,062 (49) 22,923 (54)
Reliability
PSR (MLE) 0.762 0.537/0.517/0.575 0.758 0.501/0.497/0.564 0.825 0.713/0.619/0.545
Note. The table shows the results of the tests of unidimensionality based on paired t-tests of person-location estimates for subsets of items. It also reports fractal
indexes, c, A and r. The person separation index (PSI) and fractal indexes were estimated for the complete dataset (HLS-Q12 n = 696, HL-SF12 n = 680, HLS-EU-Q47
n = 670). Significant t-tests ≤5% (or lower confidence interval [CI] proportion ≤ 5%), small drops in PSI (b after adjusting for violations of local independence due to
subtest structure), high values of A and r, and low values of c could indicate unidimensionality. Analyses were performed by using RUMM2030 software
Log-likelihoods and person separation reliability (PSR) were estimated for the one- and three-dimensional approaches to the short versions by using ConQuest4
software. Lower values of deviance and AIC indicate a better fit
AIC: Akaike’s information criterion, ep: number of estimated parameters, na: not applicable, PSR (MLE): person separation reliability based on a marginal maximum
likelihood estimate
All the short versions are developed on the basis of the HLS-EU-Q47
aHLS-Q12 developed through the present study
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recommends a complex 12-multidimensional approach
returning 12 subscale-scores for each individual. This is of
little practical use, especially as proficiency cannot be
compared across the different subscales owing to relative
points of zero. Owing to few items in each subscale, few
of the 12 subscales were sufficiently reliable.
Contrary to common practice when using the HLS-
EU-Q47, we cannot recommend reporting either total or
health domain subscale scores. The three-dimensional ap-
proach, reflecting the three health domains, obtained better
data-model fit than the one-dimensional approaches. The
three health domain subscales each returned sufficiently
large reliability indexes, but lower indexes than those re-
ported by the HLS-EU Consortium [11], Nakayama et al.
[18] and Duong et al. [19].
Prior research on people with chronic disease (type 2
diabetes) [20] indicates that the HC subscale brings not-
able multidimensionality into the data. It is very interest-
ing that this not was supported in our recent analyses of a
national sample, because it indicates that the “health care”
subscale actually work differently for patients with chronic
disease than in the population as a whole. This seems rea-
sonable, as people with chronic disease have more experi-
ences with using health care facilities than the general
population.
Analyses of HLS-EU-Q47 at item-level
Like previous studies [20, 21] we observed items violat-
ing local independence, items displaying DIF, and poorly
fitting items. Poorly fitting items which over- or
under-discriminate tap into constructs other than the
latent trait [64]. Over-discriminating items measure
“too much of something else” that is positively corre-
lated with the latent trait and are therefore viewed as
less problematic than under-discriminating items. Con-
trary to Finbråten et al. [20], who found that few items
displayed DIF in people with chronic disease (type 2
diabetes), we found several items displaying DIF for age
and education, which means that people with higher
versus lower levels of education, as well as younger
versus older people, probably perceive these items dif-
ferently. Consequently, comparisons of HL across age
groups or educational levels would be invalid [54]. The
increased number of items displaying DIF in our study
might be expected as the sample of people with type 2
diabetes in Finbråten et al. [20] mainly consisted of
elderly persons.
Psychometric properties of the of HLS-Q12, HL-SF12 and
HLS-EU-Q16
Overall analyses of the of the HLS-Q12, HL-SF12 and HLS-
EU-Q16
Based on the PCA and t-test procedures in RUMM,
none of the short versions stood out as sufficiently uni-
dimensional. However, considering the lower binominal
95% CI proportions of 0.07, the two 12 item versions
HLS-Q12 and HL-SF12 could be considered sufficiently
unidimensional [54]. Hagell [41] claims that the width of
Table 4 Overall fit and reliability using confirmatory factor analyses of the various short versions
HLS-Q12a HL-SF12 [26] HLS-EU-Q16 [11]
GOF index (LISREL) One-dimensional Three-dimensional One-dimensional Three-dimensional One-dimensional Three-dimensional
SB scaled χ2 (df),
χ2 p-value
142.71 (54),
p < 0.001
112.96 (51)
p < 0.001
93.73 (54),
p < 0.001
83.71 (51)
p < 0.01
379.12 (104),
p < 0.001
283.57 (101)
p < 0.001
SRMR 0.059 0.056 0.047 0.045 0.080 0.070
RMSEA (90% CI) 0.086
(0.078–0.095)
0.078
(0.069–0.087)
0.066
(0.057–0.076)
0.064
(0.055–0.074)
0.118
(0.112–0.124)
0.103
(0.097–0.110)
CFI 0.951 0.966 0.975 0.979 0.923 0.949
NNFI (TLI) 0.940 0.955 0.969 0.973 0.911 0.939
Log-likelihoods
-2ln(L)(ep) 6857 (24) 6787 (27) 6718 (24) 6696 (27) 8105 (32) 7851 (35)
AIC (ep) 6905 (24) 6841 (27) 6766 (24) 6750 (27) 8169 (32) 7921 (35)
BIC (ep) 7014 (24) 6964 (27) 6874 (24) 6872 (27) 8313 (32) 8078 (35)
Reliability
Coefficient H 0.826 0.663/0.608/0.713 0.822 0.591/0.599/0.622 0.882 0.823/0.720/0.667
Note. The table shows goodness of fit (GOF) indexes, log-likelihood and reliability using confirmatory factor analysis (CFA) when treating the various short versions
as one- and three-dimensional. CFA was performed using LISREL software
SB scaled χ2 :Satorra-Bentler scaled chi-square. SRMR (standardised root mean square residual) and RMSEA (root-mean-squared error of approximation): values
< 0.05 indicate good model fit, and values < 0.08 indicate an acceptable model fit. CFI (comparative fit index) and NNFI (non-normed fit index [or TLI = Tucker and
Lewis fit index]): values > 0.95 indicate good model fit (Hu and Bentler, 1999)
-2ln(L): likelihood function, AIC: Akaike’s information criterion, BIC: Bayesian information criterion, ep: number of estimated parameters. Lower values indicate a
better overall fit
aHLS-Q12 developed through the present study
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the binominal 95% CI is influenced by sample size.
When investigating dimensionality in a larger sample,
binominal 95% CI-proportions might represent accept-
able values. Moreover, unidimensionality is a relative
matter and depends on the level of precision. Evaluation
of unidimensionality should also include an assessment
of the purpose of the measurement, together with theor-
etical and practical considerations [30, 41].
Comparing the one- and three-dimensional approaches
to the short versions, the three-dimensional approach
obtained lowest deviance and sufficient values for the
GOF indexes. Like some previous studies [32, 65] we
found that Rasch modelling and CFA returned similar
results. Thus, a three-dimensional approach could be rec-
ommended for the short versions. However, when apply-
ing a three-dimensional approach the three subscales
obtained low reliability indexes. The difference in deviance
between the one- and three-dimensional approaches was
significant; but the differences were rather small for the
two 12 item versions.
A one-dimensional approach to the HLS-Q12 and
HL-SF12 could probably be defensible as the results point
to minor violations of unidimensionality. Further, the
one-dimensional approach yields higher reliability indexes
than each of the subscales of the three-dimensional ap-
proach. Providing one HL score for each individual, the
one-dimensional approach to the HLS-Q12 and the
HL-SF12 is practical from a clinical point of view. In
addition, the HLS-Q12 and HL-SF12 are in line with the
conceptual model of Sørensen et al. [16], but dimensional-
ity should be further explored in future studies.
Comparing various short versions
Comparing the psychometric properties of the various
short versions, the HLS-Q12 obtained best fit to the Rasch
model, whereas the HL-SF12 obtained best fit through
CFA. The HL-SF12 was found to have several weaknesses,
including items with unordered response categories (item
15) and several items displaying DIF (items 15, 26 and 30).
Owing to a larger number of items, the HLS-EU-Q16
stood out as more reliable than the other short versions
[63]. However, the HLS-EU-Q16 could not be considered
sufficiently unidimensional, it had the highest AIC, and
did not yield acceptable GOF indexes. In addition, prob-
lems regarding item misfit, DIF and unordered response
categories were observed.
Altogether, the HLS-Q12 has better psychometric prop-
erties than the HL-SF12 and the HLS-EU-Q16. The
HLS-Q12 can be deemed the best-targeted scale and free
from under-discriminating items and DIF. The HLS-Q12
reflects the conceptual framework, and it is well balanced
because it consists of one item from each of the 12 dimen-
sions. The HLS-Q12 version could be well suited for use
in HL screenings at both the individual and community
levels. Nevertheless, in future studies, we recommend
extending the number of response categories from four to
six to increase the reliability of the scale [66]. However,
item 38 represents a specific concern because this item
under-discriminated when applying one-, three- and
12-dimensional approaches to the entire HLS-EU-Q47. In
contrast, when we applied a one-dimensional approach to
the HLS-Q12, the item showed good model fit. In future
validation of the HLS-Q12, this item should be further
investigated.
Item difficulty
Using the HLS-Q12, items 28 (judge if the information on
health risks in the media is reliable) and 10 (judge the ad-
vantages and disadvantages of different treatment options)
were the hardest items to endorse. Consequently, people
may use information that is not evidence-based and po-
tentially harmful to their health. Hence, health profes-
sionals should guide individuals in accessing valid and
reliable health information. Further, health professionals
should help individuals to develop the ability to critically
assess health information from different sources. People
also need guidance in judging the advantages and disad-
vantages of various treatment options. Low HL might
cause difficulties with promoting and taking responsibility
for one’s own health, as well as participating in shared
descision-making regarding health issues. According to
Nutbeam [67], nurses and other health professionals must
become aware of the effects of low HL. Hence, nurses and
other health professionals should map HL in their patients
and adapt health communications to the individual or tar-
get group.
Further research on HL among Norwegians is needed,
especially research examining the correlation between
HL and health behaviour and the correlation between
access to and the use of health services. It would also be
interesting to compare HL across cultures and national-
ities. However, before comparing HL across nations and
cultures, DIF analyses should be performed to investi-
gate the effects of cultural differences on participants’ in-
terpretations of the content of the items.
Limitations
Ipsos, the agency that performed the sampling and data
collection, guarantees representativeness. However, the
educational level of this sample was higher than that of
the average Norwegian population. In this study, more
than half of participants had education at the university
level, while this is true of only 33% of the general popu-
lation [68].
Although around 1000 individuals were recruited from
each of the included EU countries, 900 individuals were
included in this study. In Rasch modelling, there is no
exact recommendations for sample size. However, Linacre
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[69] recommends 250 individuals for polytomous data
and 10 extra individuals per response category. Hair [70]
recommends at least 300 individuals when performing
CFA. According to these recommendations, a sample size
of 900 would be sufficient.
The HLS-Q12 was developed based on the results of
Rasch modelling of the HLS-EU-Q47 using two popula-
tions, people with type 2 diabetes [20] and the general
Norwegian population. However, its further application
to other populations will yield more evidence regarding
the validity and reliability of the scale. Future validation
should be performed using multinational data.
Conclusions
The HLS-EU-Q47 was found to best fit a 12-dimensional
model, which indicates that a multidimensional approach
should be applied when the entire HLS-EU-Q47 is used to
measure HL. Consequently, it is not statistically defensible
to calculate total HL scores for individuals on the basis of
the HLS-EU-Q47, and the estimate of HL for a person
cannot be derived from his or her raw score on the
HLS-EU-Q47. Relying on 12 different but related scale
scores for individuals may be impractical from a clinical
point of view. Several items on the HLS-EU-Q47 showed
misfit, DIF or unordered response categories, which indi-
cates the need to revise the scale. One should be careful in
implementing HL actions based on scores obtained via
the HLS-EU-Q47. Hence, instruments should be thor-
oughly validated before being used in large-population
surveys.
This study showed that the HLS-EU-Q47 suffers
under particular weaknesses. However, our parsimonious
HLS-Q12 meets the assumptions and the requirements
of objective measurement while still reflecting the con-
ceptual HL model scaffolding the HLS-EU-Q47. Health
professionals aiming to adapt their communication to
patients’ HL will obviously benefit from a measurement
scale like the HLS-Q12 as it could be considered a clin-
ically feasible screening instrument, which does not re-
quire advanced on-site psychometric methods. The
economic gains that might lie in rationalising health care
by applying the short but sufficient HLS-Q12 is relevant
for the development of health policies. Researchers aim-
ing to understand which factors impact HL and how HL
is related to health outcomes will definitely benefit from
an HL scale with sufficient psychometric quality. More
importantly, the conclusions from such research have
the potential to feed further information back into
policymaking.
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